Vertex Pharmaceuticals
17 ноября, 15:09

Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3

  • 0

After rising 15.4% in the first nine months of the year, the Medical-Biotech /Genetics industry has declined 13.4% so far in the fourth quarter.

15 ноября, 16:16

Biotech Stock Roundup: Dynavax Vaccine Gets FDA Nod, Loxo Inks Deal with Bayer

Regulatory actions and licensing and collaboration agreements were the key highlights this week with companies like Loxo Oncology (LOXO) remaining in the limelight.

13 ноября, 22:20

Vertex Gets CHMP Recommendation for Orkambi Label Expansion

Vertex (VRTX) received CHMP recommendation for label expansion of Orkambi in children aged 6 to 11 years with CF who have two copies of the F508del mutation.

09 ноября, 16:28

Biotech Stock Roundup: Regeneron Delivers Strong Q3 Results, Cellectis Clinical Hold Lifted

While focus remained on Regeneron's (REGN) Q3 earnings, Dicerna was also in the news related to its collaboration agreement with Boehringer Ingelheim.

01 ноября, 16:24

Biotech Stock Roundup: Celgene, Amgen, Gilead Hit by Q3 Results, Vertex Beats on All Fronts

It was all about earnings this week with major biotech companies like Gilead (GILD), Celgene and Amgen reporting third quarter results.

26 октября, 18:51

Vertex (VRTX) Beats on Q3 Earnings & Sales, Raises 2017 View

Vertex Pharma (VRTX) third-quarter earnings increased from the year-ago period led by strong sales of CF drugs.

24 октября, 16:12

Drug/Biotech Stocks Q3 Earnings on Oct 25: AMGN, GSK, VRTX

The pharma/biotech industry has seen a solid start to Q3 earnings as evident from J&J's encouraging results. Let's see if some of the other leading players - Amgen, Glaxo and Vertex - follow suit.

Выбор редакции
24 октября, 15:48

Why Earnings Season Could Be Great for Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals (VRTX) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

24 октября, 01:16

Is Celgene (CELG) Poised for a Beat This Earnings Season?

Celgene Corporation (CELG) is expected to beat estimates once again on the back of strong performance of key drug Revlimid.

13 октября, 16:17

Vertex Pharmaceuticals, USG and J. Jill highlighted as Zacks Bull and Bear of the Day

Vertex Pharmaceuticals, USG and J. Jill highlighted as Zacks Bull and Bear of the Day

13 октября, 14:00

Bull of the Day: Vertex Pharmaceuticals (VRTX)

Bull of the Day: Vertex Pharmaceuticals (VRTX)

11 октября, 16:00

Is a Beat in Store for Abbott (ABT) This Earnings Season?

Abbott's (ABT) FreeStyle Libre system receives back-to-back reimbursement approvals in several geographies, which are likely to drive growth in the Diabetes Care sales segment within Medical group.

11 октября, 15:07

Biotech Stock Roundup: Amgen's Imlygic Data Promising, Regeneron Scores Win in PCSK9 Lawsuit

With third quarter earnings round the corner, it was a relatively slow week with key updates including Regeneron (REGN) and partner Sanofi's win in the PCSK9 litigation.

10 октября, 18:00

Amgen Label Expansion Application for Prolia Accepted by FDA

Amgen (AMGN) announced that the FDA has accepted its regulatory application in the U.S. seeking label expansion for Prolia for treating patients with glucocorticoid-induced osteoporosis (GIOP).

10 октября, 17:01

5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings

Here is a look at 5 pharma and biotech stocks including Pfizer (PFE) that are expected to post a positive earnings surprise in Q3.

Выбор редакции
10 октября, 16:00

Why the Earnings Streak Will Continue for Cigna (CI)

Cigna (CI) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.

04 октября, 14:54

Biotech Stock Roundup: Endocyte Shoots up on Deal, Amgen-AbbVie Settle Humira Litigation

Key highlights this week include Amgen's (AMGN) agreement with AbbVie related to its biosimilar version of Humira and Endocyte's in-licensing deal which sent its shares soaring.

03 октября, 16:30

3 Top-Ranked Big Biotech Stocks to Buy Now

With biotech stocks on a tear, here we have picked three of the biggest biotech companies which look well poised for growth and can be added to one's portfolio

29 сентября, 16:01

Mallinckrodt (MNK) Closes InfaCare Pharmaceutical Buyout

Mallinckrodt (MNK) acquires privately-held InfaCare Pharmaceutical Corporation to diversify portfolio.

27 сентября, 21:07

Top Stock Reports for Goldman Sachs, PepsiCo and Johnson & Johnson

Top Stock Reports for Goldman Sachs, PepsiCo and Johnson & Johnson